AI-Powered Drug Delivery Market Size, Share & Trends Analysis Report By Technology, By Application, By Route of Administration, By End User, By Region And Segment Forecasts 2026 – 2035

AI-Powered Drug Delivery refers to advanced systems that utilize artificial intelligence algorithms to enhance the precision, timing, and personalization of medication administration through devices like wearables and implants.

Key factors include the rising prevalence of chronic diseases, technological advancements in AI and delivery devices, integration with telemedicine, and collaborations between tech and pharmaceutical sectors.

The market is projected to grow from an estimated USD 2.5 billion in 2025 to USD 18.3 billion by 2035.

The CAGR is expected to be 22.1% during the forecast period.

North America will contribute notably, driven by advanced infrastructure and high investments in AI healthcare technologies.

Major players include BD, Medtronic, Insulet Corporation, Novartis International AG, and Johnson & Johnson Services, Inc.

The report provides comprehensive analysis, including market size, trends, segmentation, dynamics, regional insights, key players, and forecasts.

Stages include research and development, manufacturing of AI-integrated devices, distribution, clinical integration, and post-market surveillance.

Trends are shifting towards non-invasive, personalized systems with AI for remote monitoring, while consumers prefer user-friendly devices that improve adherence and reduce side effects.

Regulatory factors involve stringent approvals for AI reliability and data privacy, while environmental factors include sustainable manufacturing practices for devices and reducing electronic waste from wearables.